
“Looking for the very highest quality products and the consistency of a high-tech pharmaceuticals operation? Vida expects to file its licensing application before the end of April, a schedule that should allow it to have the necessary license in hand by the third quarter of this year. In the meantime, the company is raising $1.5 million at $.25 per share. That represents a market value of only $6 million for a company that now owns a 315,000-square-foot production plant with a replacement value estimated at $30 million. Personally, I think this will turn out to be an extraordinary investment. In less than a year’s time, this $.25 financing round is going to look extremely cheap.”
Related posts:
Bloomberg Host Gifted Bitcoin On TV And It Immediately Got Stolen
16-Year-Old Questioned by FBI Over You Tube Video
Dad and Daughter Hauled Off United Flight, Assumed Sex Trafficker
Philadelphia Brewing Company Accepting Bitcoin As Payment
SWAT team sent to home of CNN’s Wolf Blitzer
Bank Of England To The Fed: "No Indication Should, Of Course, Be Given To The Bundesbank..."
Glenn Greenwald: Dems Rehabilitate and Unify With Bush-Era Neocons
Greek Taxes Are So High That People Are Turning Down Inheritances
Price Inflation Watch: Average NYC Rent Passes $3,000
Interactive Map Shows How Much America's Prisons Cost Taxpayers
Not So Merry Christmas Drug Busts
Why You Might Only Be Able to Get Part-Time Work in 2013
Armed Mundanes: The Reason Why SWAT Teams Exist
Additional $2.1M Seized from Mt. Gox Accounts – Now Over $5M Total
LTE wireless connections used by billions aren’t as secure as we thought